Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telemedicine | 43 | 2021 | 3109 | 3.090 |
Why?
|
Remote Consultation | 15 | 2021 | 242 | 2.200 |
Why?
|
Dermatology | 18 | 2020 | 905 | 1.550 |
Why?
|
Internet | 19 | 2013 | 3110 | 1.100 |
Why?
|
Malpractice | 2 | 2021 | 561 | 0.980 |
Why?
|
Self Care | 5 | 2016 | 799 | 0.860 |
Why?
|
Medical Informatics | 4 | 2014 | 743 | 0.780 |
Why?
|
Patient Compliance | 6 | 2019 | 2697 | 0.730 |
Why?
|
Delivery of Health Care | 14 | 2018 | 5367 | 0.710 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2024 | 445 | 0.690 |
Why?
|
Photography | 6 | 2020 | 537 | 0.650 |
Why?
|
Diffusion of Innovation | 5 | 2011 | 724 | 0.640 |
Why?
|
Quality Assurance, Health Care | 4 | 2015 | 2176 | 0.550 |
Why?
|
Drug Discovery | 1 | 2024 | 1068 | 0.540 |
Why?
|
Acne Vulgaris | 4 | 2013 | 352 | 0.540 |
Why?
|
Practice Management, Medical | 2 | 2015 | 191 | 0.490 |
Why?
|
Biomedical Technology | 3 | 2015 | 210 | 0.490 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 93 | 0.480 |
Why?
|
Monitoring, Ambulatory | 2 | 2015 | 358 | 0.460 |
Why?
|
Sunburn | 1 | 2015 | 156 | 0.450 |
Why?
|
Blood Glucose Self-Monitoring | 3 | 2012 | 475 | 0.450 |
Why?
|
Patient Participation | 3 | 2021 | 1447 | 0.430 |
Why?
|
Consumer Health Information | 2 | 2014 | 215 | 0.430 |
Why?
|
Rural Health Services | 3 | 2006 | 394 | 0.410 |
Why?
|
Skin Neoplasms | 6 | 2021 | 5863 | 0.410 |
Why?
|
Information Management | 1 | 2013 | 100 | 0.410 |
Why?
|
Dermatitis, Atopic | 1 | 2019 | 737 | 0.400 |
Why?
|
Prehypertension | 1 | 2012 | 63 | 0.400 |
Why?
|
Decision Support Systems, Clinical | 2 | 2017 | 1178 | 0.390 |
Why?
|
Occupational Health Services | 1 | 2012 | 149 | 0.380 |
Why?
|
Exercise | 4 | 2020 | 5955 | 0.350 |
Why?
|
Hair | 7 | 1996 | 508 | 0.350 |
Why?
|
Psoriasis | 3 | 2009 | 926 | 0.340 |
Why?
|
Skin Diseases | 9 | 2020 | 1085 | 0.330 |
Why?
|
Health Care Reform | 4 | 2014 | 1256 | 0.330 |
Why?
|
Chronic Disease | 5 | 2016 | 9384 | 0.330 |
Why?
|
Forecasting | 7 | 2020 | 2945 | 0.330 |
Why?
|
Telecommunications | 1 | 2009 | 79 | 0.330 |
Why?
|
Keratins | 6 | 1994 | 499 | 0.320 |
Why?
|
Keratinocytes | 5 | 1995 | 876 | 0.320 |
Why?
|
Sociology | 1 | 2008 | 21 | 0.320 |
Why?
|
Sunscreening Agents | 1 | 2009 | 139 | 0.320 |
Why?
|
Mind-Body Therapies | 1 | 2012 | 294 | 0.310 |
Why?
|
Protein Precursors | 8 | 1995 | 1134 | 0.300 |
Why?
|
Office Visits | 3 | 2020 | 595 | 0.300 |
Why?
|
Patient Readmission | 4 | 2018 | 3288 | 0.300 |
Why?
|
Monitoring, Physiologic | 5 | 2016 | 1798 | 0.290 |
Why?
|
Heart Failure | 7 | 2021 | 11879 | 0.290 |
Why?
|
Access to Information | 2 | 2009 | 317 | 0.280 |
Why?
|
Health Services Accessibility | 9 | 2021 | 5520 | 0.280 |
Why?
|
Hospital Information Systems | 1 | 2009 | 395 | 0.280 |
Why?
|
Workplace | 2 | 2012 | 873 | 0.280 |
Why?
|
Medication Adherence | 3 | 2016 | 2187 | 0.280 |
Why?
|
Nursing Care | 2 | 2005 | 65 | 0.270 |
Why?
|
Reminder Systems | 1 | 2009 | 388 | 0.270 |
Why?
|
Physicians | 2 | 2021 | 4598 | 0.260 |
Why?
|
Humans | 108 | 2024 | 768166 | 0.260 |
Why?
|
Electronic Mail | 2 | 2005 | 215 | 0.260 |
Why?
|
Rosacea | 1 | 2006 | 60 | 0.240 |
Why?
|
Computer Security | 3 | 2016 | 261 | 0.240 |
Why?
|
Patient Satisfaction | 6 | 2015 | 3488 | 0.240 |
Why?
|
Pilot Projects | 10 | 2021 | 8741 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2016 | 12252 | 0.230 |
Why?
|
Silicon | 1 | 2024 | 143 | 0.230 |
Why?
|
Congresses as Topic | 1 | 2009 | 812 | 0.230 |
Why?
|
Overweight | 2 | 2012 | 2448 | 0.220 |
Why?
|
Health Behavior | 1 | 2015 | 2650 | 0.220 |
Why?
|
United States | 25 | 2021 | 73039 | 0.220 |
Why?
|
Telepathology | 1 | 2004 | 77 | 0.220 |
Why?
|
Health Promotion | 1 | 2015 | 2210 | 0.210 |
Why?
|
Technology Assessment, Biomedical | 1 | 2005 | 312 | 0.200 |
Why?
|
Leg Injuries | 1 | 2004 | 180 | 0.200 |
Why?
|
Attitude to Computers | 1 | 2003 | 196 | 0.190 |
Why?
|
Nurse Practitioners | 2 | 2019 | 271 | 0.190 |
Why?
|
Relative Value Scales | 1 | 2021 | 85 | 0.190 |
Why?
|
Carbon | 1 | 2024 | 673 | 0.180 |
Why?
|
Cambodia | 3 | 2006 | 185 | 0.180 |
Why?
|
Current Procedural Terminology | 1 | 2021 | 101 | 0.180 |
Why?
|
Costs and Cost Analysis | 2 | 2021 | 1667 | 0.170 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2006 | 951 | 0.170 |
Why?
|
Epidermis | 6 | 1995 | 539 | 0.170 |
Why?
|
Liability, Legal | 1 | 2021 | 209 | 0.170 |
Why?
|
Alopecia | 3 | 1996 | 416 | 0.170 |
Why?
|
Information Dissemination | 3 | 2014 | 1143 | 0.160 |
Why?
|
Isotretinoin | 1 | 2021 | 134 | 0.160 |
Why?
|
Minoxidil | 3 | 1988 | 35 | 0.160 |
Why?
|
Epoprostenol | 2 | 1992 | 246 | 0.160 |
Why?
|
Hair Diseases | 2 | 1996 | 72 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 3 | 2020 | 388 | 0.150 |
Why?
|
Skin | 9 | 2020 | 4503 | 0.150 |
Why?
|
Expert Systems | 1 | 2017 | 79 | 0.150 |
Why?
|
Internal Medicine | 1 | 2005 | 1064 | 0.150 |
Why?
|
Health Services Research | 1 | 2005 | 1815 | 0.140 |
Why?
|
Emergency Medical Service Communication Systems | 1 | 2017 | 21 | 0.140 |
Why?
|
Health Services Needs and Demand | 2 | 2019 | 1406 | 0.140 |
Why?
|
Insurance Carriers | 1 | 2018 | 159 | 0.140 |
Why?
|
Organizational Case Studies | 2 | 2013 | 301 | 0.140 |
Why?
|
Hospitalization | 6 | 2024 | 10840 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2012 | 4530 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 443 | 0.130 |
Why?
|
Male | 39 | 2024 | 364719 | 0.130 |
Why?
|
Triage | 2 | 2020 | 997 | 0.130 |
Why?
|
Female | 37 | 2024 | 397192 | 0.120 |
Why?
|
Hypertension | 2 | 2012 | 8616 | 0.120 |
Why?
|
Middle Aged | 27 | 2024 | 223492 | 0.120 |
Why?
|
Transglutaminases | 3 | 1994 | 200 | 0.120 |
Why?
|
Computer Communication Networks | 3 | 2011 | 295 | 0.120 |
Why?
|
Nails | 2 | 1993 | 298 | 0.110 |
Why?
|
Quality of Health Care | 3 | 2016 | 4310 | 0.110 |
Why?
|
Intermediate Filaments | 1 | 1994 | 171 | 0.110 |
Why?
|
Organophosphorus Compounds | 1 | 2015 | 211 | 0.110 |
Why?
|
Organizational Innovation | 2 | 2014 | 540 | 0.110 |
Why?
|
Modems | 1 | 2013 | 2 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1141 | 0.110 |
Why?
|
Patient Care Team | 2 | 2019 | 2523 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 916 | 0.110 |
Why?
|
Health Plan Implementation | 2 | 2014 | 338 | 0.110 |
Why?
|
Quinazolinones | 1 | 2015 | 219 | 0.110 |
Why?
|
Dermoscopy | 2 | 2015 | 73 | 0.110 |
Why?
|
Financing, Personal | 2 | 2006 | 310 | 0.110 |
Why?
|
Education, Medical | 1 | 2005 | 1742 | 0.110 |
Why?
|
Aged | 22 | 2024 | 171504 | 0.110 |
Why?
|
Commerce | 1 | 2018 | 612 | 0.110 |
Why?
|
Computers | 2 | 2007 | 592 | 0.100 |
Why?
|
Massachusetts | 5 | 2012 | 8890 | 0.100 |
Why?
|
Cadaverine | 1 | 1992 | 9 | 0.100 |
Why?
|
Cost Control | 1 | 2015 | 627 | 0.100 |
Why?
|
Physical Examination | 2 | 1997 | 1263 | 0.100 |
Why?
|
Health Policy | 3 | 2018 | 2698 | 0.100 |
Why?
|
Argininosuccinic Aciduria | 1 | 1991 | 11 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 246 | 0.090 |
Why?
|
Miniaturization | 1 | 2011 | 154 | 0.090 |
Why?
|
Nails, Malformed | 1 | 1991 | 34 | 0.090 |
Why?
|
Electric Power Supplies | 1 | 2011 | 96 | 0.090 |
Why?
|
Adult | 21 | 2020 | 223646 | 0.090 |
Why?
|
Nail Diseases | 1 | 1991 | 54 | 0.090 |
Why?
|
Patient Care | 2 | 2014 | 629 | 0.090 |
Why?
|
3T3 Cells | 1 | 1992 | 1084 | 0.090 |
Why?
|
Diagnostic Equipment | 1 | 2009 | 11 | 0.090 |
Why?
|
Electronic Health Records | 4 | 2018 | 4887 | 0.080 |
Why?
|
Medication Errors | 1 | 2016 | 786 | 0.080 |
Why?
|
Feasibility Studies | 6 | 2021 | 5315 | 0.080 |
Why?
|
Veterans Health | 1 | 2011 | 216 | 0.080 |
Why?
|
Physician-Patient Relations | 3 | 2015 | 3269 | 0.080 |
Why?
|
Documentation | 1 | 2016 | 917 | 0.080 |
Why?
|
Patient Education as Topic | 3 | 2024 | 2337 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 4 | 2017 | 3231 | 0.080 |
Why?
|
Focus Groups | 2 | 2012 | 1460 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9613 | 0.080 |
Why?
|
Quality of Life | 4 | 2021 | 13490 | 0.080 |
Why?
|
Community Networks | 1 | 2011 | 202 | 0.080 |
Why?
|
Palliative Care | 1 | 2024 | 3643 | 0.080 |
Why?
|
Microscopy, Immunoelectron | 3 | 1995 | 316 | 0.080 |
Why?
|
Proteins | 3 | 1995 | 6009 | 0.080 |
Why?
|
Boston | 3 | 2013 | 9374 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2012 | 646 | 0.080 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1991 | 283 | 0.080 |
Why?
|
Information Storage and Retrieval | 2 | 2015 | 830 | 0.080 |
Why?
|
Videoconferencing | 2 | 2015 | 209 | 0.080 |
Why?
|
Melanoma | 1 | 2006 | 5706 | 0.070 |
Why?
|
Economics | 1 | 2008 | 141 | 0.070 |
Why?
|
Disease | 1 | 2013 | 675 | 0.070 |
Why?
|
Societies | 1 | 2008 | 107 | 0.070 |
Why?
|
Evaluation Studies as Topic | 3 | 2006 | 1627 | 0.070 |
Why?
|
Self-Help Groups | 1 | 2009 | 194 | 0.070 |
Why?
|
Hoof and Claw | 1 | 1986 | 12 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2024 | 65371 | 0.070 |
Why?
|
Microscopy, Electron | 4 | 1996 | 2560 | 0.070 |
Why?
|
Arachidonic Acids | 1 | 1987 | 296 | 0.070 |
Why?
|
Information Services | 1 | 2007 | 239 | 0.070 |
Why?
|
User-Computer Interface | 2 | 2011 | 1407 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3573 | 0.070 |
Why?
|
Developing Countries | 3 | 2015 | 2910 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2012 | 1443 | 0.060 |
Why?
|
Economic Competition | 1 | 2008 | 223 | 0.060 |
Why?
|
Physicians, Family | 1 | 2008 | 349 | 0.060 |
Why?
|
Occupational Health | 1 | 2012 | 812 | 0.060 |
Why?
|
Confidentiality | 2 | 2016 | 607 | 0.060 |
Why?
|
Physician Assistants | 1 | 2008 | 190 | 0.060 |
Why?
|
Computer Systems | 2 | 2015 | 469 | 0.060 |
Why?
|
California | 1 | 2009 | 1438 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 2 | 2009 | 1196 | 0.060 |
Why?
|
Referral and Consultation | 4 | 2021 | 3620 | 0.060 |
Why?
|
Facial Dermatoses | 1 | 2006 | 87 | 0.060 |
Why?
|
Depression | 3 | 2015 | 8230 | 0.060 |
Why?
|
Time Management | 1 | 2005 | 53 | 0.060 |
Why?
|
Neoplasms | 4 | 2024 | 22371 | 0.060 |
Why?
|
Hirsutism | 1 | 1985 | 68 | 0.060 |
Why?
|
Radiology Information Systems | 1 | 2009 | 533 | 0.060 |
Why?
|
Internship and Residency | 1 | 2005 | 5953 | 0.060 |
Why?
|
Reimbursement Mechanisms | 3 | 2015 | 670 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2479 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2923 | 0.060 |
Why?
|
Medically Underserved Area | 1 | 2006 | 268 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2004 | 71 | 0.050 |
Why?
|
Social Environment | 1 | 2008 | 1012 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2021 | 81762 | 0.050 |
Why?
|
Disease Management | 1 | 2014 | 2536 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3706 | 0.050 |
Why?
|
Program Evaluation | 1 | 2012 | 2507 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3109 | 0.050 |
Why?
|
Critical Care | 1 | 2016 | 2715 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8748 | 0.050 |
Why?
|
Specialization | 1 | 2008 | 779 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4091 | 0.050 |
Why?
|
Cell Line | 4 | 1995 | 15597 | 0.050 |
Why?
|
Aged, 80 and over | 8 | 2018 | 59629 | 0.050 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 550 | 0.050 |
Why?
|
Research Design | 2 | 2016 | 6211 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 5 | 1993 | 2474 | 0.050 |
Why?
|
Reference Values | 1 | 2009 | 4938 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1489 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2029 | 0.050 |
Why?
|
Primary Prevention | 1 | 2009 | 1188 | 0.050 |
Why?
|
Patient Care Management | 1 | 2005 | 303 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2359 | 0.050 |
Why?
|
Demography | 1 | 2006 | 1641 | 0.050 |
Why?
|
Quality Improvement | 2 | 2014 | 3857 | 0.050 |
Why?
|
Membrane Proteins | 3 | 1995 | 7876 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6607 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1397 | 0.050 |
Why?
|
Nursing Homes | 1 | 2009 | 1084 | 0.050 |
Why?
|
Interprofessional Relations | 2 | 2007 | 997 | 0.050 |
Why?
|
Child | 6 | 2020 | 80917 | 0.050 |
Why?
|
6-Ketoprostaglandin F1 alpha | 2 | 1992 | 80 | 0.040 |
Why?
|
Motivation | 3 | 2019 | 2020 | 0.040 |
Why?
|
Habits | 1 | 2021 | 148 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1994 | 1730 | 0.040 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2021 | 300 | 0.040 |
Why?
|
Mucinosis, Follicular | 1 | 1999 | 8 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9118 | 0.040 |
Why?
|
Pain | 1 | 2015 | 5100 | 0.040 |
Why?
|
Young Adult | 6 | 2013 | 60066 | 0.040 |
Why?
|
Substrate Specificity | 2 | 1994 | 1751 | 0.040 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2000 | 146 | 0.040 |
Why?
|
Eccrine Glands | 1 | 1999 | 52 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7454 | 0.040 |
Why?
|
Time Factors | 4 | 2011 | 40218 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 1986 | 985 | 0.040 |
Why?
|
Prospective Studies | 4 | 2020 | 54926 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1444 | 0.040 |
Why?
|
Carrier Proteins | 1 | 1992 | 4937 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2004 | 1165 | 0.040 |
Why?
|
Molecular Weight | 3 | 1992 | 2173 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6809 | 0.040 |
Why?
|
Models, Economic | 1 | 2003 | 719 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 89169 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39348 | 0.040 |
Why?
|
Blood Glucose | 2 | 2009 | 6430 | 0.040 |
Why?
|
Arachidonic Acid | 2 | 1992 | 429 | 0.040 |
Why?
|
Melitten | 2 | 1988 | 13 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7951 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 24315 | 0.040 |
Why?
|
Primary Health Care | 2 | 2008 | 4746 | 0.040 |
Why?
|
Software | 1 | 2011 | 4478 | 0.040 |
Why?
|
Bradykinin | 2 | 1988 | 205 | 0.040 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 1999 | 210 | 0.030 |
Why?
|
Anxiety | 1 | 2012 | 4672 | 0.030 |
Why?
|
Epitopes | 3 | 1992 | 2528 | 0.030 |
Why?
|
Psychiatry | 1 | 2009 | 1716 | 0.030 |
Why?
|
History, 21st Century | 1 | 2003 | 1573 | 0.030 |
Why?
|
Medical Errors | 1 | 2005 | 1260 | 0.030 |
Why?
|
Privacy | 1 | 2018 | 233 | 0.030 |
Why?
|
Cattle | 5 | 1990 | 3819 | 0.030 |
Why?
|
Communication | 1 | 2011 | 3905 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3390 | 0.030 |
Why?
|
Health Care Costs | 3 | 2017 | 3239 | 0.030 |
Why?
|
Hospitalists | 1 | 2020 | 298 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2009 | 4055 | 0.030 |
Why?
|
Antibodies, Monoclonal | 5 | 1993 | 9263 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10632 | 0.030 |
Why?
|
Parents | 1 | 2009 | 3595 | 0.030 |
Why?
|
Technology, High-Cost | 1 | 2015 | 32 | 0.030 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 1995 | 15 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3929 | 0.030 |
Why?
|
Waiting Lists | 1 | 2020 | 779 | 0.030 |
Why?
|
Isoelectric Focusing | 1 | 1995 | 149 | 0.030 |
Why?
|
Empirical Research | 1 | 2015 | 119 | 0.030 |
Why?
|
Intermediate Filament Proteins | 2 | 1986 | 261 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3447 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2766 | 0.030 |
Why?
|
Blotting, Western | 2 | 1992 | 5027 | 0.030 |
Why?
|
Disaster Planning | 1 | 2020 | 560 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1995 | 240 | 0.030 |
Why?
|
Efficiency, Organizational | 2 | 2009 | 697 | 0.030 |
Why?
|
Body Mass Index | 1 | 2012 | 13053 | 0.030 |
Why?
|
Animals, Newborn | 2 | 1992 | 2678 | 0.030 |
Why?
|
Testosterone | 1 | 1985 | 2491 | 0.030 |
Why?
|
Observer Variation | 1 | 2020 | 2622 | 0.030 |
Why?
|
Pain Measurement | 1 | 2024 | 3583 | 0.030 |
Why?
|
Avidin | 1 | 1993 | 44 | 0.030 |
Why?
|
Age Factors | 2 | 2009 | 18412 | 0.030 |
Why?
|
Horseradish Peroxidase | 1 | 1993 | 170 | 0.030 |
Why?
|
Accreditation | 1 | 2016 | 476 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1993 | 221 | 0.030 |
Why?
|
Licensure | 1 | 2014 | 127 | 0.030 |
Why?
|
Public Health | 1 | 2006 | 2679 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3415 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1673 | 0.030 |
Why?
|
Cells, Cultured | 5 | 1992 | 19015 | 0.030 |
Why?
|
Technology | 1 | 2015 | 296 | 0.030 |
Why?
|
Iloprost | 1 | 1992 | 25 | 0.030 |
Why?
|
Biotin | 1 | 1993 | 256 | 0.020 |
Why?
|
Putrescine | 1 | 1992 | 42 | 0.020 |
Why?
|
Developed Countries | 1 | 2015 | 451 | 0.020 |
Why?
|
Argininosuccinic Acid | 1 | 1991 | 6 | 0.020 |
Why?
|
Argininosuccinate Lyase | 1 | 1991 | 8 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1993 | 238 | 0.020 |
Why?
|
Risk Factors | 4 | 2013 | 74944 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1989 | 0.020 |
Why?
|
Microscopy, Polarization | 1 | 1991 | 88 | 0.020 |
Why?
|
Mitomycin | 1 | 1992 | 261 | 0.020 |
Why?
|
Autoradiography | 1 | 1992 | 727 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 1992 | 388 | 0.020 |
Why?
|
Animals | 13 | 1995 | 169246 | 0.020 |
Why?
|
Self Administration | 1 | 2012 | 386 | 0.020 |
Why?
|
Syndrome | 1 | 1996 | 3272 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2012 | 285 | 0.020 |
Why?
|
Policy Making | 1 | 2014 | 546 | 0.020 |
Why?
|
Stroke | 2 | 2004 | 9755 | 0.020 |
Why?
|
Emergencies | 1 | 2016 | 1221 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 416 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1991 | 944 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2011 | 286 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 1994 | 11095 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1995 | 1103 | 0.020 |
Why?
|
Porphyrias | 1 | 1989 | 57 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8744 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 1992 | 794 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.020 |
Why?
|
Immunotherapy | 1 | 2005 | 4755 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 1998 | 1506 | 0.020 |
Why?
|
Psychology | 1 | 2011 | 353 | 0.020 |
Why?
|
Mice | 7 | 1995 | 82029 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2016 | 1078 | 0.020 |
Why?
|
Protoporphyrins | 1 | 1989 | 168 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1080 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1993 | 1081 | 0.020 |
Why?
|
Data Collection | 2 | 2009 | 3327 | 0.020 |
Why?
|
Vitamin A | 1 | 1992 | 611 | 0.020 |
Why?
|
Genes, Recessive | 1 | 1991 | 625 | 0.020 |
Why?
|
Professional Practice | 1 | 2011 | 314 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 1991 | 693 | 0.020 |
Why?
|
Prostaglandins F | 1 | 1988 | 80 | 0.020 |
Why?
|
Informed Consent | 1 | 2015 | 1010 | 0.020 |
Why?
|
Shiga Toxins | 1 | 1988 | 39 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14164 | 0.020 |
Why?
|
Dexamethasone | 2 | 1987 | 1965 | 0.020 |
Why?
|
Prostaglandins E | 1 | 1988 | 166 | 0.020 |
Why?
|
Cricetinae | 1 | 1992 | 2423 | 0.020 |
Why?
|
Treatment Refusal | 1 | 2011 | 433 | 0.020 |
Why?
|
Dinoprost | 1 | 1988 | 139 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1157 | 0.020 |
Why?
|
Awareness | 1 | 2012 | 654 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1988 | 863 | 0.020 |
Why?
|
Epithelium | 1 | 1992 | 1607 | 0.020 |
Why?
|
Porphyrins | 1 | 1989 | 352 | 0.020 |
Why?
|
Calcimycin | 1 | 1987 | 214 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5622 | 0.020 |
Why?
|
Blood Pressure | 2 | 2013 | 8543 | 0.020 |
Why?
|
Cell Differentiation | 4 | 1992 | 11669 | 0.020 |
Why?
|
Diglycerides | 1 | 1987 | 176 | 0.020 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 1987 | 82 | 0.020 |
Why?
|
Trisomy | 1 | 1987 | 260 | 0.020 |
Why?
|
Insurance, Health | 1 | 2018 | 2517 | 0.020 |
Why?
|
Keratoacanthoma | 1 | 1986 | 33 | 0.020 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 1987 | 319 | 0.020 |
Why?
|
Program Development | 1 | 2012 | 1300 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1987 | 452 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1987 | 826 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2013 | 1542 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13290 | 0.020 |
Why?
|
Carcinogens | 1 | 1987 | 453 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2566 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1998 | 2517 | 0.020 |
Why?
|
Hydrolases | 1 | 1986 | 146 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 10399 | 0.020 |
Why?
|
Amino Acids | 1 | 1991 | 1716 | 0.020 |
Why?
|
Dinoprostone | 1 | 1988 | 597 | 0.020 |
Why?
|
Administration, Topical | 1 | 1987 | 703 | 0.010 |
Why?
|
Parent-Child Relations | 1 | 2009 | 772 | 0.010 |
Why?
|
Hair Removal | 1 | 1985 | 41 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3814 | 0.010 |
Why?
|
Dihydrotestosterone | 1 | 1985 | 195 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1988 | 1534 | 0.010 |
Why?
|
Home Care Services | 1 | 2011 | 659 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1987 | 697 | 0.010 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2014 | 1188 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 12421 | 0.010 |
Why?
|
Dehydroepiandrosterone | 1 | 1985 | 259 | 0.010 |
Why?
|
Antibodies | 1 | 1991 | 2421 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2840 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 13421 | 0.010 |
Why?
|
Nose | 1 | 1986 | 522 | 0.010 |
Why?
|
China | 1 | 2009 | 2395 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1992 | 6231 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1999 | 20227 | 0.010 |
Why?
|
Protein Binding | 1 | 1994 | 9343 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 1988 | 922 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 1985 | 560 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 2007 | 724 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 1985 | 553 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2434 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17622 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1999 | 9015 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2009 | 2741 | 0.010 |
Why?
|
Spironolactone | 1 | 1985 | 415 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 13014 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3533 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3968 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2013 | 3205 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2721 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14783 | 0.010 |
Why?
|
Hospitals | 1 | 2014 | 3886 | 0.010 |
Why?
|
Mice, Nude | 1 | 1986 | 3623 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2784 | 0.010 |
Why?
|
Erythrocytes | 1 | 1989 | 2418 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15869 | 0.010 |
Why?
|
Social Support | 1 | 2009 | 2193 | 0.010 |
Why?
|
Models, Organizational | 1 | 2002 | 548 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1987 | 2846 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30010 | 0.010 |
Why?
|
Immunoelectrophoresis | 2 | 1987 | 94 | 0.010 |
Why?
|
Genomics | 1 | 2013 | 5926 | 0.010 |
Why?
|
Dementia | 1 | 2011 | 2740 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14729 | 0.010 |
Why?
|
Rats | 3 | 1987 | 23760 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9092 | 0.010 |
Why?
|
Hyperplasia | 1 | 1999 | 1151 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1999 | 794 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1988 | 4427 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2004 | 2055 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2004 | 1223 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12077 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15454 | 0.010 |
Why?
|
Child, Preschool | 2 | 1992 | 42669 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1992 | 26422 | 0.010 |
Why?
|
Whales | 1 | 1990 | 30 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1986 | 4058 | 0.010 |
Why?
|
Cell Division | 2 | 1987 | 4473 | 0.010 |
Why?
|
Haplorhini | 1 | 1990 | 523 | 0.010 |
Why?
|
Infant | 1 | 1991 | 36535 | 0.000 |
Why?
|
Acute Disease | 1 | 1999 | 7243 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 26379 | 0.000 |
Why?
|
Cross Reactions | 1 | 1990 | 828 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6793 | 0.000 |
Why?
|
Sheep | 1 | 1990 | 1451 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1987 | 213 | 0.000 |
Why?
|
Cell Survival | 2 | 1987 | 5777 | 0.000 |
Why?
|
Chromatography, Gel | 1 | 1987 | 636 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15948 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15662 | 0.000 |
Why?
|
Chromatography, Affinity | 1 | 1987 | 525 | 0.000 |
Why?
|
Karyotyping | 1 | 1987 | 1177 | 0.000 |
Why?
|
Dogs | 1 | 1990 | 3845 | 0.000 |
Why?
|
Feces | 1 | 1989 | 1511 | 0.000 |
Why?
|
Cohort Studies | 1 | 2004 | 41754 | 0.000 |
Why?
|
Cell Membrane | 1 | 1987 | 3655 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1987 | 10760 | 0.000 |
Why?
|
Calcium | 1 | 1987 | 5792 | 0.000 |
Why?
|